nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—ADRB2—polycystic ovary syndrome	0.767	1	CbGaD
Betaxolol—Emotional distress—Metformin—polycystic ovary syndrome	0.00537	0.0609	CcSEcCtD
Betaxolol—Acidosis—Metformin—polycystic ovary syndrome	0.00413	0.0468	CcSEcCtD
Betaxolol—Respiratory distress—Metformin—polycystic ovary syndrome	0.0036	0.0408	CcSEcCtD
Betaxolol—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00282	0.032	CcSEcCtD
Betaxolol—Rigors—Metformin—polycystic ovary syndrome	0.0028	0.0317	CcSEcCtD
Betaxolol—Accidental injury—Metformin—polycystic ovary syndrome	0.00258	0.0293	CcSEcCtD
Betaxolol—Neuropathy—Metformin—polycystic ovary syndrome	0.00214	0.0243	CcSEcCtD
Betaxolol—Ear pain—Metformin—polycystic ovary syndrome	0.00194	0.022	CcSEcCtD
Betaxolol—Injury—Metformin—polycystic ovary syndrome	0.0018	0.0204	CcSEcCtD
Betaxolol—Renal impairment—Metformin—polycystic ovary syndrome	0.00174	0.0197	CcSEcCtD
Betaxolol—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.0017	0.0193	CcSEcCtD
Betaxolol—Lethargy—Metformin—polycystic ovary syndrome	0.00169	0.0192	CcSEcCtD
Betaxolol—Alprenolol—ADRB3—polycystic ovary syndrome	0.00151	0.154	CrCbGaD
Betaxolol—Breast disorder—Metformin—polycystic ovary syndrome	0.0015	0.017	CcSEcCtD
Betaxolol—Cramp muscle—Metformin—polycystic ovary syndrome	0.00149	0.0169	CcSEcCtD
Betaxolol—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00148	0.0168	CcSEcCtD
Betaxolol—Influenza—Metformin—polycystic ovary syndrome	0.00143	0.0162	CcSEcCtD
Betaxolol—Angina pectoris—Metformin—polycystic ovary syndrome	0.0014	0.0158	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00133	0.0151	CcSEcCtD
Betaxolol—Pindolol—ADRB3—polycystic ovary syndrome	0.0013	0.132	CrCbGaD
Betaxolol—Infestation NOS—Metformin—polycystic ovary syndrome	0.00128	0.0145	CcSEcCtD
Betaxolol—Infestation—Metformin—polycystic ovary syndrome	0.00128	0.0145	CcSEcCtD
Betaxolol—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00125	0.0142	CcSEcCtD
Betaxolol—Bradycardia—Metformin—polycystic ovary syndrome	0.00117	0.0132	CcSEcCtD
Betaxolol—Rhinitis—Metformin—polycystic ovary syndrome	0.00115	0.013	CcSEcCtD
Betaxolol—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00114	0.0129	CcSEcCtD
Betaxolol—Eye disorder—Metformin—polycystic ovary syndrome	0.00107	0.0122	CcSEcCtD
Betaxolol—Flushing—Metformin—polycystic ovary syndrome	0.00106	0.0121	CcSEcCtD
Betaxolol—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00106	0.0121	CcSEcCtD
Betaxolol—Angiopathy—Metformin—polycystic ovary syndrome	0.00104	0.0118	CcSEcCtD
Betaxolol—Immune system disorder—Metformin—polycystic ovary syndrome	0.00104	0.0117	CcSEcCtD
Betaxolol—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00103	0.0117	CcSEcCtD
Betaxolol—Chills—Metformin—polycystic ovary syndrome	0.00103	0.0117	CcSEcCtD
Betaxolol—Malnutrition—Metformin—polycystic ovary syndrome	0.000999	0.0113	CcSEcCtD
Betaxolol—Erythema—Metformin—polycystic ovary syndrome	0.000999	0.0113	CcSEcCtD
Betaxolol—Dysgeusia—Metformin—polycystic ovary syndrome	0.000978	0.0111	CcSEcCtD
Betaxolol—Muscle spasms—Metformin—polycystic ovary syndrome	0.00096	0.0109	CcSEcCtD
Betaxolol—Vision blurred—Metformin—polycystic ovary syndrome	0.000941	0.0107	CcSEcCtD
Betaxolol—Tremor—Metformin—polycystic ovary syndrome	0.000936	0.0106	CcSEcCtD
Betaxolol—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000927	0.0105	CcSEcCtD
Betaxolol—Malaise—Metformin—polycystic ovary syndrome	0.000901	0.0102	CcSEcCtD
Betaxolol—Syncope—Metformin—polycystic ovary syndrome	0.000896	0.0101	CcSEcCtD
Betaxolol—Palpitations—Metformin—polycystic ovary syndrome	0.000883	0.01	CcSEcCtD
Betaxolol—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000878	0.00995	CcSEcCtD
Betaxolol—Chest pain—Metformin—polycystic ovary syndrome	0.00085	0.00964	CcSEcCtD
Betaxolol—Myalgia—Metformin—polycystic ovary syndrome	0.00085	0.00964	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000844	0.00957	CcSEcCtD
Betaxolol—Discomfort—Metformin—polycystic ovary syndrome	0.00084	0.00952	CcSEcCtD
Betaxolol—Oedema—Metformin—polycystic ovary syndrome	0.000815	0.00924	CcSEcCtD
Betaxolol—Infection—Metformin—polycystic ovary syndrome	0.00081	0.00918	CcSEcCtD
Betaxolol—Shock—Metformin—polycystic ovary syndrome	0.000802	0.00909	CcSEcCtD
Betaxolol—Chlorphenesin—CYP19A1—polycystic ovary syndrome	0.0008	0.0813	CrCbGaD
Betaxolol—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000799	0.00906	CcSEcCtD
Betaxolol—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000798	0.00904	CcSEcCtD
Betaxolol—Skin disorder—Metformin—polycystic ovary syndrome	0.000792	0.00897	CcSEcCtD
Betaxolol—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000788	0.00893	CcSEcCtD
Betaxolol—Esmolol—ADRB2—polycystic ovary syndrome	0.000786	0.08	CrCbGaD
Betaxolol—Anorexia—Metformin—polycystic ovary syndrome	0.000777	0.0088	CcSEcCtD
Betaxolol—Hypotension—Metformin—polycystic ovary syndrome	0.000762	0.00863	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000743	0.00842	CcSEcCtD
Betaxolol—Paraesthesia—Metformin—polycystic ovary syndrome	0.000732	0.00829	CcSEcCtD
Betaxolol—Dyspnoea—Metformin—polycystic ovary syndrome	0.000727	0.00824	CcSEcCtD
Betaxolol—Dyspepsia—Metformin—polycystic ovary syndrome	0.000717	0.00813	CcSEcCtD
Betaxolol—Propranolol—ADRB3—polycystic ovary syndrome	0.00071	0.0722	CrCbGaD
Betaxolol—Decreased appetite—Metformin—polycystic ovary syndrome	0.000708	0.00803	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000704	0.00797	CcSEcCtD
Betaxolol—Fatigue—Metformin—polycystic ovary syndrome	0.000703	0.00796	CcSEcCtD
Betaxolol—Constipation—Metformin—polycystic ovary syndrome	0.000697	0.0079	CcSEcCtD
Betaxolol—Atenolol—ADRB2—polycystic ovary syndrome	0.000686	0.0698	CrCbGaD
Betaxolol—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000672	0.00761	CcSEcCtD
Betaxolol—Bisoprolol—ADRB2—polycystic ovary syndrome	0.000669	0.068	CrCbGaD
Betaxolol—Urticaria—Metformin—polycystic ovary syndrome	0.000647	0.00734	CcSEcCtD
Betaxolol—Acebutolol—ADRB2—polycystic ovary syndrome	0.000633	0.0644	CrCbGaD
Betaxolol—Oxprenolol—ADRB2—polycystic ovary syndrome	0.000629	0.0639	CrCbGaD
Betaxolol—Asthenia—Metformin—polycystic ovary syndrome	0.000585	0.00663	CcSEcCtD
Betaxolol—Pruritus—Metformin—polycystic ovary syndrome	0.000577	0.00654	CcSEcCtD
Betaxolol—Alprenolol—ADRB2—polycystic ovary syndrome	0.000575	0.0585	CrCbGaD
Betaxolol—Diarrhoea—Metformin—polycystic ovary syndrome	0.000558	0.00632	CcSEcCtD
Betaxolol—Dizziness—Metformin—polycystic ovary syndrome	0.000539	0.00611	CcSEcCtD
Betaxolol—Metoprolol—ADRB2—polycystic ovary syndrome	0.000534	0.0544	CrCbGaD
Betaxolol—Vomiting—Metformin—polycystic ovary syndrome	0.000518	0.00587	CcSEcCtD
Betaxolol—Rash—Metformin—polycystic ovary syndrome	0.000514	0.00582	CcSEcCtD
Betaxolol—Dermatitis—Metformin—polycystic ovary syndrome	0.000513	0.00582	CcSEcCtD
Betaxolol—Headache—Metformin—polycystic ovary syndrome	0.000511	0.00579	CcSEcCtD
Betaxolol—Pindolol—ADRB2—polycystic ovary syndrome	0.000495	0.0503	CrCbGaD
Betaxolol—Nausea—Metformin—polycystic ovary syndrome	0.000484	0.00549	CcSEcCtD
Betaxolol—Propranolol—ADRB2—polycystic ovary syndrome	0.00027	0.0274	CrCbGaD
Betaxolol—Propranolol—CYP1A1—polycystic ovary syndrome	0.000231	0.0235	CrCbGaD
Betaxolol—ADRB1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000107	0.000799	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000106	0.00079	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000106	0.000786	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000105	0.000784	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000105	0.000781	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000104	0.000772	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000103	0.000769	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000103	0.000766	CbGpPWpGaD
Betaxolol—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000103	0.000765	CbGpPWpGaD
Betaxolol—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000103	0.000764	CbGpPWpGaD
Betaxolol—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000101	0.000753	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	9.66e-05	0.000719	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—FSHR—polycystic ovary syndrome	9.59e-05	0.000714	CbGpPWpGaD
Betaxolol—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	9.59e-05	0.000713	CbGpPWpGaD
Betaxolol—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	9.45e-05	0.000703	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	9.45e-05	0.000703	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—FSHR—polycystic ovary syndrome	9.38e-05	0.000698	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	9.35e-05	0.000696	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	9.35e-05	0.000696	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	9.3e-05	0.000692	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NPB—polycystic ovary syndrome	9.27e-05	0.00069	CbGpPWpGaD
Betaxolol—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	9.19e-05	0.000684	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—LHB—polycystic ovary syndrome	9.19e-05	0.000684	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	9.1e-05	0.000677	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NPB—polycystic ovary syndrome	9.07e-05	0.000675	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—LHB—polycystic ovary syndrome	8.99e-05	0.000669	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	8.98e-05	0.000668	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	8.89e-05	0.000661	CbGpPWpGaD
Betaxolol—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	8.81e-05	0.000655	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	8.78e-05	0.000654	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	8.77e-05	0.000653	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—SCT—polycystic ovary syndrome	8.61e-05	0.000641	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	8.58e-05	0.000638	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	8.44e-05	0.000628	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—SCT—polycystic ovary syndrome	8.42e-05	0.000627	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	8.39e-05	0.000624	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—LHB—polycystic ovary syndrome	8.34e-05	0.000621	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	8.26e-05	0.000615	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—GNAS—polycystic ovary syndrome	8.24e-05	0.000613	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	8.21e-05	0.000611	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	8.2e-05	0.000611	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—LHB—polycystic ovary syndrome	8.16e-05	0.000607	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	8.15e-05	0.000607	CbGpPWpGaD
Betaxolol—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	8.12e-05	0.000604	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—GNAS—polycystic ovary syndrome	8.06e-05	0.0006	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	8.03e-05	0.000598	CbGpPWpGaD
Betaxolol—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	8.01e-05	0.000596	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	7.98e-05	0.000594	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	7.83e-05	0.000583	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—SCT—polycystic ovary syndrome	7.82e-05	0.000582	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LHCGR—polycystic ovary syndrome	7.74e-05	0.000576	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PTGER3—polycystic ovary syndrome	7.74e-05	0.000576	CbGpPWpGaD
Betaxolol—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	7.73e-05	0.000575	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—SCT—polycystic ovary syndrome	7.65e-05	0.000569	CbGpPWpGaD
Betaxolol—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	7.62e-05	0.000567	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PTGER3—polycystic ovary syndrome	7.57e-05	0.000563	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LHCGR—polycystic ovary syndrome	7.57e-05	0.000563	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	7.46e-05	0.000555	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	7.43e-05	0.000553	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	7.3e-05	0.000543	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	7.28e-05	0.000542	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PTAFR—polycystic ovary syndrome	7.24e-05	0.000539	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	7.13e-05	0.00053	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	7.08e-05	0.000527	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PTAFR—polycystic ovary syndrome	7.08e-05	0.000527	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	7.03e-05	0.000523	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	6.88e-05	0.000512	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	6.84e-05	0.000509	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	6.8e-05	0.000506	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	6.69e-05	0.000498	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—INHBB—polycystic ovary syndrome	6.66e-05	0.000496	CbGpPWpGaD
Betaxolol—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	6.55e-05	0.000487	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—INHBB—polycystic ovary syndrome	6.52e-05	0.000485	CbGpPWpGaD
Betaxolol—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	6.46e-05	0.00048	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.22e-05	0.000463	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	6.22e-05	0.000463	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	6.22e-05	0.000463	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.09e-05	0.000453	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	6.07e-05	0.000451	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	6.02e-05	0.000448	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	5.93e-05	0.000442	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	5.78e-05	0.00043	CbGpPWpGaD
Betaxolol—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	5.76e-05	0.000429	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	5.76e-05	0.000428	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FSHR—polycystic ovary syndrome	5.67e-05	0.000422	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—POMC—polycystic ovary syndrome	5.55e-05	0.000413	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	5.54e-05	0.000412	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.51e-05	0.00041	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	5.49e-05	0.000409	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	5.43e-05	0.000404	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.39e-05	0.000401	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	5.37e-05	0.000399	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.33e-05	0.000396	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	5.27e-05	0.000392	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	5.27e-05	0.000392	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.21e-05	0.000388	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	5.2e-05	0.000387	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.18e-05	0.000386	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.07e-05	0.000377	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FST—polycystic ovary syndrome	5.05e-05	0.000376	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	5.02e-05	0.000374	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.99e-05	0.000371	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	4.94e-05	0.000368	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LHB—polycystic ovary syndrome	4.93e-05	0.000367	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	4.91e-05	0.000366	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	4.91e-05	0.000366	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	4.9e-05	0.000364	CbGpPWpGaD
Betaxolol—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	4.88e-05	0.000363	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.88e-05	0.000363	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	4.82e-05	0.000359	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.82e-05	0.000358	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	4.79e-05	0.000356	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.71e-05	0.000351	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.67e-05	0.000347	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.66e-05	0.000346	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SCT—polycystic ovary syndrome	4.62e-05	0.000344	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.56e-05	0.00034	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.56e-05	0.000339	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.55e-05	0.000339	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	4.52e-05	0.000336	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	4.47e-05	0.000332	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.41e-05	0.000328	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FGF18—polycystic ovary syndrome	4.33e-05	0.000322	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.31e-05	0.000321	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RBP4—polycystic ovary syndrome	4.29e-05	0.000319	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	4.24e-05	0.000315	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	4.24e-05	0.000315	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.23e-05	0.000315	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	4.2e-05	0.000313	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	4.16e-05	0.00031	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	4.16e-05	0.00031	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.14e-05	0.000308	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	4.12e-05	0.000306	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—YAP1—polycystic ovary syndrome	4.01e-05	0.000298	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	4e-05	0.000298	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GAB1—polycystic ovary syndrome	3.95e-05	0.000294	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.94e-05	0.000293	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	3.92e-05	0.000292	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	3.9e-05	0.00029	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	3.87e-05	0.000288	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—INSR—polycystic ovary syndrome	3.78e-05	0.000281	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	3.72e-05	0.000277	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	3.7e-05	0.000275	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.59e-05	0.000267	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.54e-05	0.000263	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.51e-05	0.000261	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PGR—polycystic ovary syndrome	3.5e-05	0.00026	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	3.49e-05	0.00026	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.46e-05	0.000257	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	3.42e-05	0.000255	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	3.32e-05	0.000247	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	3.31e-05	0.000246	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GHRL—polycystic ovary syndrome	3.25e-05	0.000242	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PLAT—polycystic ovary syndrome	3.25e-05	0.000242	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	3.18e-05	0.000237	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	3.18e-05	0.000237	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	3.17e-05	0.000236	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	3.15e-05	0.000235	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.13e-05	0.000233	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.12e-05	0.000232	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ATF1—polycystic ovary syndrome	3.1e-05	0.000231	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.07e-05	0.000228	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	3.04e-05	0.000226	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.03e-05	0.000225	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.01e-05	0.000224	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.96e-05	0.00022	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.95e-05	0.000219	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	2.89e-05	0.000215	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NGFR—polycystic ovary syndrome	2.86e-05	0.000213	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	2.85e-05	0.000212	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	2.84e-05	0.000211	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	2.82e-05	0.00021	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	2.81e-05	0.000209	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	2.8e-05	0.000209	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	2.78e-05	0.000207	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	2.78e-05	0.000207	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.74e-05	0.000204	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	2.73e-05	0.000203	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.69e-05	0.0002	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	2.68e-05	0.0002	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.68e-05	0.000199	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.65e-05	0.000197	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	2.52e-05	0.000187	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.51e-05	0.000187	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.5e-05	0.000186	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	2.45e-05	0.000182	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.44e-05	0.000182	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	2.44e-05	0.000181	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	2.39e-05	0.000178	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.38e-05	0.000177	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	2.35e-05	0.000175	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	2.34e-05	0.000174	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.33e-05	0.000173	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	2.32e-05	0.000172	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.28e-05	0.00017	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	2.26e-05	0.000168	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	2.23e-05	0.000166	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	2.13e-05	0.000159	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	2.1e-05	0.000157	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	2.07e-05	0.000154	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	2.06e-05	0.000154	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	2e-05	0.000149	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	1.99e-05	0.000148	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	1.96e-05	0.000146	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.96e-05	0.000146	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	1.91e-05	0.000142	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	1.91e-05	0.000142	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.9e-05	0.000141	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.89e-05	0.00014	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.87e-05	0.000139	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.79e-05	0.000133	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.78e-05	0.000133	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	1.75e-05	0.000131	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.75e-05	0.00013	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.74e-05	0.00013	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.71e-05	0.000127	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	1.68e-05	0.000125	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	1.67e-05	0.000124	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	1.65e-05	0.000122	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.64e-05	0.000122	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	1.64e-05	0.000122	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.62e-05	0.00012	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.62e-05	0.00012	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.58e-05	0.000118	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.58e-05	0.000118	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.54e-05	0.000114	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—TH—polycystic ovary syndrome	1.52e-05	0.000113	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.5e-05	0.000112	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.48e-05	0.00011	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.46e-05	0.000109	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	1.39e-05	0.000104	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.39e-05	0.000103	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	1.32e-05	9.83e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	1.24e-05	9.22e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.24e-05	9.2e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	1.23e-05	9.17e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.21e-05	9e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	1.18e-05	8.79e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.12e-05	8.33e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.06e-05	7.86e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	1.04e-05	7.77e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.03e-05	7.69e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	9.99e-06	7.43e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	9.85e-06	7.33e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—INS—polycystic ovary syndrome	9.8e-06	7.29e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	8.46e-06	6.3e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	8.35e-06	6.21e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—INS—polycystic ovary syndrome	8.3e-06	6.18e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	7.31e-06	5.44e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	7.15e-06	5.32e-05	CbGpPWpGaD
